Full Press Release Details
PARTICIPATION IN LEERINK, NWR HEALTHCARE CONFERENCES
Sydney, Australia - 13 March 2025 - Radiopharm Theranostics
(ASX:RAD, "Radiopharm" or the "Company"), a developer of a world-class
platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce ongoing and upcoming conference
Radiopharm's Chief Medical Officer Dr Dimitris Voliotis is participating
in the Leerink Partners Global Healthcare Conference 2025 in Miami, Florida, USA this week, taking numerous meetings with a range of professional
and institutional investors.
Additionally, Dr Voliotis will present at the NWR Virtual Healthcare
Conference at 9:40am AEDT on Wednesday 19 March 2025.
Shareholders, investors and interested parties are encouraged to register
to attend the presentation at the following link: https://us02web.zoom.us/webinar/register/WN_I3oC9hkOSmiUVa_fJhybCw
A recording will be available at the above link shortly after the conclusion
of the live session, and the replay will also be available via the Company's website and social media channels.
Questions can be submitted on the day or sent in advance to matt@nwrcommunications.com.au
For more information please visit: https://nwrcommunications.com/healthconf
About Radiopharm Theranostics
Radiopharm Theranostics is a clinical stage radiotherapeutics company
developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high
unmet medical need. Radiopharm has been listed on ASX (RAD) since November 2021. The company has a deep pipeline of highly differentiated
molecules spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development.
The pipeline has been built based on the potential to be first-to-market or best-in-class. The clinical program includes one Phase II
and three Phase I trials in a variety of solid tumour cancers including brain, lung, breast and pancreas. Learn more at radiopharmtheranostics.com.
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
Authorized on behalf of the Radiopharm Theranostics Board of Directors
by Executive Chairman Paul Hopper.
For more information:
CEO & Managing Director
Follow Radiopharm Theranostics:
Website - https://radiopharmtheranostics.com/
Twitter - https://twitter.com/TeamRadiopharm
InvestorHub - https://investorhub.radiopharmtheranostics.com/
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia